Application and Monitoring of Vasoactive and Inotrope Drugs
Launched by JOHANNES GUTENBERG UNIVERSITY MAINZ · Apr 5, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how doctors use and monitor certain medications called vasoactive and inotrope drugs in patients who are having non-cardiac surgeries and experiencing hemodynamic instability, which means their blood flow and pressure are not stable. The goal is to understand the current practices among anesthesiologists in Germany regarding these medications.
If you are an anesthesiologist in Germany, you might be eligible to participate in this study. The trial is currently recruiting participants, and it's a great opportunity for doctors to contribute to improving patient care. Participants in the trial will share their experiences and practices in using these medications, which could help enhance how patients are treated during surgery. It's important to note that only anesthesiologists who can fully respond to the study's questions are eligible to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all anesthesiologists of germany
- Exclusion Criteria:
- • not completely responses
About Johannes Gutenberg University Mainz
Johannes Gutenberg University Mainz, a leading research institution in Germany, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research and education to address critical health challenges. Its commitment to ethical standards and scientific rigor ensures that clinical trials are conducted with the utmost integrity, aiming to translate research findings into effective therapies and improved patient outcomes. Through its robust infrastructure and expert faculty, Johannes Gutenberg University Mainz plays a pivotal role in enhancing the landscape of clinical research and contributing to global health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mainz, Rhineland Palatinate, Germany
Patients applied
Trial Officials
Marc Kriege
Principal Investigator
University Medical Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported